Heart Transplantation

Artificial heart pump trial to begin in the U.K.

Published in Blood Weekly, August 26th, 2004

VentrAssist, a new type of pump to help failing hearts, will undergo clinical trials in autumn 2004 in the U.K.

Its design is intended to solve the problems of mechanical failure and blood clotting that have bedevilled artificial hearts and pumps since they were invented. The pump also has a curious side effect: people implanted with the device have no pulse.

The VentrAssist, which is made by Australian company Ventracor, is of a type known as left ventricular assist devices. LVADs are not designed to replace the heart but are implanted alongside it under the rib cage. They augment the pumping action of the left ventricle - the heart's main chamber...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-08-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry